Some families of cell surface receptors, such as integrins α4β1 and α2β1 [24], have been reported to be regulators of both tumor angiogenesis and lymphangiogenesis, indicating that angiogenesis-related proteins may also have similar effects on lymphangiogenesis. The gene discussed is CD177; the disease is neoplasm.